Marrow aspirate and biopsy, flow cytometry and genetics: which test answers which question
- Reading the test
A marrow sample is split between several tests, each answering a different question. Knowing which one you need avoids a second procedure.
What it is
A bone marrow examination takes liquid marrow (the aspirate) and a core of bone with marrow (the trephine biopsy), usually from the posterior iliac crest. The aspirate shows individual cells and feeds the special tests: flow cytometry (which proteins the cells carry), cytogenetics and FISH (chromosomes), molecular tests (gene mutations and fusion genes) and culture. The biopsy shows the architecture: how full the marrow is, fibrosis, and infiltration by tumour or granulomas.
What it measures and the numbers that matter
- Aspirate: cell morphology, the differential count and blast percentage, the myeloid to erythroid ratio, iron stores and ringed sideroblasts (iron stain).
- Trephine biopsy: cellularity (roughly 100 minus the age, in percent, as a rough guide), fibrosis (reticulin stain), patchy infiltration and granulomas.
- Flow cytometry: lineage (myeloid, B, T, plasma cell), maturity (blasts) and clonality (kappa or lambda light chain restriction in B cells).
- Cytogenetics needs living, dividing cells and takes days to weeks; FISH targets known changes and is faster; PCR detects and measures fusion genes such as BCR::ABL1; sequencing panels find point mutations.
- A 'dry tap' (no aspirate) suggests fibrosis, hairy cell leukaemia or a tightly packed marrow; the biopsy is then essential.
- Many diagnoses need no marrow: CLL and PNH by flow cytometry of blood, CML by blood BCR::ABL1.
How to read it, in order
- Ask the question first: diagnosis, classification and risk, staging, response, or infection.
- Check whether the blood answers it: smear, blood flow cytometry, blood PCR or serum protein tests.
- If marrow is needed, plan which tests and tubes (heparin for cytogenetics, EDTA for flow and molecular, culture bottles).
- Read the aspirate: cellularity of the smear, blasts, dysplasia, plasma cells, abnormal cells, iron.
- Read the biopsy: overall cellularity, fibrosis, infiltrates, granulomas.
- Integrate morphology, flow, genetics and the clinical picture in one report; genetics often decides the risk group.
Which test answers which question
| Test | Sample | Answers | Typical uses |
|---|---|---|---|
| Aspirate smear | Liquid marrow | Which cells, how many blasts, dysplasia, iron | Acute leukaemia, MDS, megaloblastic change, myeloma |
| Trephine biopsy | Bone core | How full, fibrosis, patchy infiltrates | Aplasia, myelofibrosis, lymphoma or cancer spread, granulomas |
| Flow cytometry | Aspirate or blood | Lineage, maturity, clonality | Leukaemia typing, CLL, lymphoma in marrow, PNH, response |
| Cytogenetics and FISH | Aspirate (living cells) | Chromosome gains, losses and translocations | Risk group in AML, ALL, MDS and myeloma |
| Molecular tests (PCR, sequencing) | Aspirate or blood | Fusion genes and mutations | BCR::ABL1, PML::RARA, JAK2, FLT3, NPM1; monitoring residual disease |
Reading errors
- A diluted 'bloody tap' can underestimate blasts or plasma cells; compare with the biopsy.
- An aspirate alone can miss patchy lymphoma or metastases that the biopsy would show.
- In fever of unknown origin, marrow culture and biopsy can find tuberculosis, histoplasmosis or visceral leishmaniasis (amastigotes in macrophages).
- Serious complications are rare; a low platelet count alone is seldom a barrier, but anticoagulants are reviewed beforehand.
Next step
- Suspected acute leukaemia: aspirate with flow cytometry, cytogenetics and molecular tests at the first procedure.
- Suspected CLL, CML or PNH: start with blood tests; marrow only if they do not answer the question.
- Pancytopenia with a dry tap: rely on the biopsy (reticulin, immunostains) and blood molecular tests.
- Suspected infection: send marrow for culture and special stains, not only morphology.
Common traps
- Doing a marrow first: when blood flow cytometry or PCR would answer the question, start with them.
- Sending only an aspirate in suspected aplasia, fibrosis or lymphoma: cellularity and patchy disease need the biopsy.
- Forgetting to send fresh sample for cytogenetics at the first marrow: it cannot be done on fixed tissue, so the procedure has to be repeated.
- Reading a low blast count in a diluted aspirate as reassuring: dilution can make the count falsely low.
Test yourself
Think of the answer, then tap the question to see it.
Why must a marrow biopsy, and not only an aspirate, be taken in suspected aplastic anaemia?
Aplasia is a judgement of how full the marrow is; only the biopsy shows true cellularity, and a dilute aspirate can look empty when the marrow is not.
Which test shows that a population of B cells is clonal, and how?
Flow cytometry: a clonal B-cell population carries only kappa or only lambda light chains, whereas reactive B cells carry a mix.
The aspirate is a dry tap. What does it suggest and what must you rely on?
Marrow fibrosis, hairy cell leukaemia or a packed marrow; the trephine biopsy, with reticulin and immunostains, must answer the question.
Why is a sample for cytogenetics sent fresh at the first procedure?
Karyotyping needs living cells that divide in culture; fixed tissue cannot be used, and the result often decides the risk group.
Elsewhere in DurgiPedia
- Marrow aspirate and biopsy: cellularity and the M:E ratio
- Bone marrow: red and yellow marrow, stroma, sinusoids, niches
- Flow cytometry and the CD4 count
- Clonality testing: telling lymphoma from a reactive response
- Endoscopy, laparoscopy and biopsies of liver, kidney, marrow and nodes
Connections
Educational content; it does not replace assessment by a doctor or your institution's protocols. It contains no doses.
Sources: Laboratory Evaluation of Bone Marrow (StatPearls (NCBI Bookshelf), 2024); Bone Marrow Tests: MedlinePlus Medical Test (MedlinePlus, US National Library of Medicine, 2025); Immunophenotyping of Peripheral Blood and Bone Marrow Cells by Flow Cytometry (EJIFCC (PubMed Central), 2006); Leishmaniasis (StatPearls Publishing (NCBI Bookshelf), 2026).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
